Victrelis Approval History
Marketing Status: Discontinued
Victrelis (boceprevir) is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C.
Development History and FDA Approval Process for Victrelis
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.